Birth outcomes in women who have taken leflunomide during pregnancy.

Arthritis and Rheumatism
C D ChambersOrganization of Teratology Information Specialists Collaborative Research Group

Abstract

In preclinical reproductive studies, leflunomide was found to be embryotoxic and teratogenic. Women treated with leflunomide are advised to avoid pregnancy; those who become pregnant are advised to reduce fetal exposure through a cholestyramine drug elimination procedure. The present study was undertaken to investigate pregnancy outcomes in women who received leflunomide and were treated with cholestyramine during pregnancy. Sixty-four pregnant women with rheumatoid arthritis (RA) who were treated with leflunomide during pregnancy (95.3% of whom received cholestyramine), 108 pregnant women with RA not treated with leflunomide, and 78 healthy pregnant women were enrolled in a prospective cohort study between 1999 and 2009. Information was collected via interview of the mothers, review of medical records, and specialized physical examination of infants. There were no significant differences in the overall rate of major structural defects in the exposed group (3 of 56 live births [5.4%]) relative to either comparison group (each 4.2%)(P = 0.13). The rate was similar to the 3-4% expected in the general population. There was no specific pattern of major or minor anomalies. Infants in both the leflunomide-exposed and non-leflunomide-...Continue Reading

References

Jun 22, 1989·The New England Journal of Medicine·K L JonesJ Adams
Apr 1, 1987·The Journal of Pediatrics·K A LeppigL B Holmes
Feb 1, 1980·Arthritis and Rheumatism·J F FriesH R Holman
Nov 29, 2001·The Annals of Pharmacotherapy·L A Boothby, P L Doering
Dec 18, 2001·Teratology·C D ChambersK Lyons Jones
Feb 14, 2002·Pediatric Dermatology·S CambiaghiC Gelmetti
Jun 17, 2005·Annals of the Rheumatic Diseases·M De SantisA Caruso
May 2, 2006·Maternal and Child Health Journal·Susan D ReedMegan A Svec

❮ Previous
Next ❯

Citations

Aug 5, 2011·American Journal of Medical Genetics. Part a·Mariya KozenkoBernard N Chodirker
Jun 4, 2011·Journal of Neurology·Dorothea Buck, Bernhard Hemmer
Jun 16, 2010·Current Neurology and Neuroscience Reports·Devon Conway, Jeffrey A Cohen
Nov 19, 2013·Best Practice & Research. Clinical Rheumatology·Aisha Lateef, Michelle Petri
Aug 22, 2012·Nature Reviews. Rheumatology·Aisha Lateef, Michelle Petri
Oct 23, 2010·Current Opinion in Obstetrics & Gynecology·Elisabeth Märker-Hermann, Rebecca Fischer-Betz
Oct 29, 2013·Annual Review of Pharmacology and Toxicology·Fatma EtwelGideon Koren
Apr 18, 2014·Drugs·Amit Bar-OrHeinz Wiendl
Oct 22, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Elisabeth ElefantCatherine Vauzelle
Dec 24, 2013·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·T BanasB Batko
Dec 17, 2014·Expert Review of Clinical Immunology·Aaron E Miller
Apr 20, 2014·Expert Opinion on Pharmacotherapy·Arianna SartoriMark S Freedman
Sep 6, 2014·Expert Opinion on Drug Safety·Maria GerosaRolando Cimaz
Feb 18, 2015·Expert Opinion on Drug Safety·Athina PapadopoulouTill Sprenger
May 21, 2013·Expert Opinion on Drug Metabolism & Toxicology·Michael D WieseCatherine O'Doherty
Feb 10, 2016·Multiple Sclerosis and Related Disorders·Giancarlo ComiThomas P Leist
Jan 14, 2016·CNS Drugs·Andrew ChanManuel Comabella
Jan 16, 2016·Journal of Midwifery & Women's Health·Susan M SinclairElizabeth M Cooper
Nov 28, 2015·Neurodegenerative Disease Management·Kerstin Hellwig
Oct 18, 2016·Rheumatology and Therapy·André DuquetteMaxime Doré
Jul 31, 2013·Neurologic Clinics·Matthew McCoyd
Jul 29, 2011·Reumatología clinica·Erardo Meriño-Ibarra, Concepción Delgado Beltrán
Mar 4, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Malte C Claussen, Thomas Korn
Jan 19, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Preeyaporn SarangarmLudmila Bakhireva
May 11, 2011·Arthritis Care & Research·Bindee KuriyaDaniel H Solomon
Jul 13, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Christina D Chambers, Diana L Johnson
Feb 7, 2012·Arthritis and Rheumatism·M CassinaUNKNOWN Organization of Teratology Information Specialists Collaborative Research Group
Apr 24, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Jane AdamsChristina Chambers
Jul 13, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Christina Chambers
Feb 8, 2014·Arthritis & Rheumatology·Seoyoung C Kim, Sonia Hernandez-Diaz
Dec 6, 2014·Rheumatology·May Ching Soh, Catherine Nelson-Piercy
Mar 26, 2013·Current Opinion in Pharmacology·Monika Østensen, Frauke Förger
Apr 30, 2016·International Journal of Rheumatic Diseases·Gene-Siew NgianSharon Van Doornum
Feb 19, 2016·Annals of the Rheumatic Diseases·Carina Götestam SkorpenMonika Østensen
May 14, 2016·Expert Review of Clinical Immunology·Frauke Förger, Peter M Villiger
Jun 11, 2016·Expert Opinion on Pharmacotherapy·Maria GerosaPier Luigi Meroni
Jul 17, 2016·Best Practice & Research. Clinical Rheumatology·Wendy MarderEmily C Somers
Dec 12, 2012·Seminars in Fetal & Neonatal Medicine·Gideon Koren, Hedvig M E Nordeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.